Developing Next-Generation Organ and Tissue Perfusion for Transplantations
About
BMI OrganBank are experts in high control, low pressure, air, and fluid flow technology solutions, with one of our many patented technologies, emulating the “push and pull” of the cardiovascular system, providing the very ‘heart’ for a series of commercial products and newly emerging devices.
The Problem
In 2021
105,800 people
were on the U.S.A. Waiting List
85%
needed a kidney
Only 27%
on the list got them
Every 10 mins
a person is added to the wait list
3-5 years average
waiting time for a kidney
17 people die
each day on that wait list
Meanwhile…
30% of donated
kidneys were not transplanted
Globally only 10%
of the transplant need is accommodated
It’s Time for These Numbers to Change
Our Solution
OrganBank™ Transport & OrganBank™ Nest
- A self-contained organ preservation system, designed to support multiple organs at a time
- Provides controlled pulsatile perfusion using an oxygenated accelluar perfusion solution in a temperature controlled setting.
- Capable of monitoring each of the hosted organs, displaying important perfusion parameters, including: perfusate flow, temperature, pressure, and vascular resistance.
- Features easily accessible aseptic organ cassettes, which facilitate quick connections and release, from/to the OrganBank portable organ transport system.
- Optionally, the OrganBank provides dialysis of the perfusion solution for extended periods of organ maintenance.
*BMI intends to seek FDA Clearance for its first mobile device in 2023 and once secured to begin by focusing on the Kidney Transplant market.
*Computer-generated images: depict envisaged commercial OrganBank™ Transport and OrganBank™ Nest